Breast Cancer News
In this section, access cutting-edge news about breast cancer in young women including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Two recent studies found that those diagnosed with breast cancer at younger ages are more likely to experience difficulties with certain symptoms and side effects than those diagnosed when older.
Life expectancy improves only slightly for women with cancer in one breast who choose to remove the healthy breast along with the affected one, a recent study shows.
Treating hormone receptor-positive breast cancer with an aromatase inhibitor, or AI, usually used only in postmenopausal women, significantly reduced breast cancer return in premenopausal women when used with ovarian suppression , according to the preliminary reports of two combined studies.
Most young women diagnosed with early-stage breast cancer are at risk of becoming infertile from treatment, according to a study from the Centers for Disease Control and Prevention (CDC) and other researchers.
Before and during chemotherapy, giving premenopausal women with estrogen receptor-negative (ER-) breast cancer the medicine goserelin (Zoladex) improved their ability to become pregnant several years after treatment and to deliver healthy babies.
Sunday reports from the 50th annual meeting of the American Society of Clinical Oncology focused on using aromatase inhibitors in premenopausal women with early-stage, estrogen-positive breast cancer and on a negative study of lapatinib for HER2-positive early-stage disease.
Researchers announced findings from breast cancer studies during Saturday’s sessions of the 50th Annual Meeting of the American Society of Clinical Oncology, in Chicago. Today's reports focus on obesity and risk of recurrence in pre- and peri-menopausal women; preserving fertility in young women taking chemotherapy; and the future of bevacizumab (Avastin) in breast cancer.
Having very young children may affect whether women receive radiation therapy after breast-conserving surgery.
The American Society of Clinical Oncology published updates to their 2005 guidelines for use of sentinel lymph node biopsy in early-stage breast cancer. The guidelines, based on the review of 9 randomized clinical trials and 13 cohort studies, reflect what ASCO believes are best practices in using the biopsy.
A recent study suggests that while women are living longer after treatment for breast cancer, they may be at greater risk of developing certain health conditions as they age.